CBS and prostate carcinoma: Studies reported that CBS is highly expressed in colon cancer (Szabo et al., 2013), ovarian cancer (Bhattacharyya et al., 2013), prostate cancer (Guo et al., 2012), and breast cancer (Sen et al., 2015).